Back

Testing for a wildlife reservoir of divergent SARS-CoV-2 in white-tailed deer

Crawshaw, L.; Kotwa, J. D.; Jeeves, S. P.; Loomer, C.; Dibernardo, A.; Stewart, A.; Newar, S. L.; Chien, E.; Yim, W.; Kruczkiewicz, P.; Vernygora, O.; Lung, O.; Schulte-Hostedde, A. I.; Maguire, F.; Pickering, B.; Jardine, C. M.; Coatsworth, H.; Mubareka, S.; Bowman, J.

2025-05-23 pathology
10.1101/2025.05.22.655348 bioRxiv
Show abstract

The 2021 discovery of a divergent lineage (B.1.641) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in white-tailed deer (Odocoileus virginianus) from Ontario raised concerns that deer were a potential reservoir. To assess whether white-tailed deer continued to be infected with B.1.641 and to test for spillover into other species, we established a surveillance program in Ontario by sampling wildlife via existing monitoring programs and through active surveillance of captive and wild animals. Between 2022 to 2024, we tested 2,839 animals, identifying one active SARS-CoV-2 infection (a likely spillover of a recombinant XBB.2.3.11.3 lineage), but no cases of B.1.641. Overall, 93 animals (6.8%) tested positive for SARS-CoV-2 antibodies, including 89 white-tailed deer, two Virginia opossums (Didelphis virginiana), one American mink (Neogale vison), and one river otter (Lontra canadensis). In Southwestern Ontario, where B.1.641 was originally detected, 15.2% of deer samples were seropositive. Generalized Linear Models demonstrated that seropositive deer were more likely to be found in areas with a higher fall deer harvest and human population density, and closer to previous B.1.641 cases. Our data suggest that deer-associated B.1.641 may have caused a relatively localized epizootic without forming a stable reservoir. This study underscores the importance of One Health-focused surveillance.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Emerging Infectious Diseases
103 papers in training set
Top 0.1%
33.5%
2
Transboundary and Emerging Diseases
34 papers in training set
Top 0.1%
6.9%
3
PLOS ONE
4510 papers in training set
Top 27%
6.5%
4
Viruses
318 papers in training set
Top 0.8%
6.4%
50% of probability mass above
5
The Lancet Infectious Diseases
71 papers in training set
Top 0.7%
3.6%
6
Scientific Reports
3102 papers in training set
Top 43%
2.8%
7
Clinical Infectious Diseases
231 papers in training set
Top 2%
2.6%
8
PLOS Pathogens
721 papers in training set
Top 5%
2.1%
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 27%
2.1%
10
Virology
56 papers in training set
Top 0.3%
1.9%
11
The American Journal of Pathology
31 papers in training set
Top 0.2%
1.8%
12
Emerging Microbes & Infections
74 papers in training set
Top 0.8%
1.7%
13
Protein Science
221 papers in training set
Top 0.8%
1.7%
14
Journal of Virology
456 papers in training set
Top 2%
1.5%
15
Parasitology
10 papers in training set
Top 0.1%
1.3%
16
Nature Communications
4913 papers in training set
Top 55%
1.3%
17
PLOS Neglected Tropical Diseases
378 papers in training set
Top 4%
1.3%
18
The Lancet
16 papers in training set
Top 0.5%
1.1%
19
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 3%
1.0%
20
Developmental & Comparative Immunology
11 papers in training set
Top 0.1%
0.9%
21
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.8%
22
Microbiology Spectrum
435 papers in training set
Top 5%
0.8%
23
iScience
1063 papers in training set
Top 31%
0.8%
24
mSphere
281 papers in training set
Top 6%
0.8%
25
One Health
29 papers in training set
Top 1%
0.8%
26
Royal Society Open Science
193 papers in training set
Top 5%
0.8%
27
Journal of General Virology
46 papers in training set
Top 0.9%
0.7%
28
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.7%
29
Pathogens
53 papers in training set
Top 2%
0.7%
30
eLife
5422 papers in training set
Top 63%
0.5%